Toxic - Sales NeoGenomics Employee Review

1.0
Oct 24, 2025
Recommend
CEO approval
Business Outlook

Pros

Benefits were good and that's about it

Cons

Completely disorganized, behind the 8-Ball with technology in the MRD space, micro-management, poor leadership, and the person over HR/people team is horrible.

avatar
NeoGenomics Response
8mo
Thank you for sharing your feedback. We take all employee input seriously and are continuously working to improve our processes, leadership, and technology so our teams can thrive. We appreciate you taking the time to share your perspective.

Explore other reviews about NeoGenomics

5.0
Mar 11, 2026
Recommend
CEO approval
Business Outlook

Pros

Growing business opportunities for many job seekers

Cons

Ever changing approach on direction on projects

2.0
Mar 2, 2026
Recommend
CEO approval
Business Outlook

Pros

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Cons

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
See reviews by: Helpful|Rating|Date|All